tiprankstipranks
Galectin Therapeutics Inc (GALT)
NASDAQ:GALT
Holding GALT?
Track your performance easily

Galectin Therapeutics (GALT) Financial Statements

565 Followers

Galectin Therapeutics Financial Overview

Galectin Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.728; its P/E ratio is -3.86; Galectin Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -11.22M$ -12.37M$ -10.44M$ -9.15M$ -9.59M
EBITDA$ -11.21M$ -12.36M$ -10.43M$ -9.14M$ -9.59M
Net Income Common Stockholders$ -11.24M$ -12.44M$ -11.50M$ -10.06M$ -14.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 27.06M$ 25.60M$ 23.55M$ 25.66M$ 20.36M
Total Assets$ 28.97M$ 27.66M$ 25.89M$ 28.20M$ 22.16M
Total Debt$ 72.94M$ 62.05M$ 51.32M$ 0.00$ 0.00
Net Debt$ 45.88M$ 36.45M$ 27.77M$ -25.66M$ -20.36M
Total Liabilities$ 121.45M$ 109.80M$ 96.98M$ 88.44M$ 73.04M
Stockholders Equity$ -94.20M$ -83.87M$ -72.81M$ -61.96M$ -52.60M
Cash Flow-
Free Cash Flow$ -8.54M$ -8.33M$ -12.11M$ -4.70M$ -7.64M
Operating Cash Flow$ -8.54M$ -8.33M$ -12.11M$ -4.70M$ -7.64M
Investing Cash Flow-----
Financing Cash Flow$ 10.00M$ 10.38M$ 10.00M$ 10.00M$ 10.03M
Currency in USD

Galectin Therapeutics Earnings and Revenue History

Galectin Therapeutics Debt to Assets

Galectin Therapeutics Cash Flow

Galectin Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis